Basic Information
ID: ALA5256307
Type: Functional
Description: Antiviral activity against SARS-CoV-2 BetaCoV/France/IDF0372/2020 infected human A549-ACE2 cells assessed as inhibition of viral replication by qRT-PCR analysis
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Strain: BetaCoV/France/IDF0372/2020
Target: SARS-CoV-2(ALA4303835)
Document: ALA5252642
Antiviral activity against SARS-CoV-2 BetaCoV/France/IDF0372/2020 infected human A549-ACE2 cells assessed as inhibition of viral replication by qRT-PCR analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5256307
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 544.67 | 1.60 | 1.60 |
| 543.66 | 2.80 | 2.80 |
| 549.74 | 3.96 | 3.96 |
| 494.66 | 3.21 | 3.21 |
| 641.88 | 4.43 | 4.43 |
| 516.69 | 3.14 | 3.14 |
| 526.66 | 2.05 | 2.05 |
| 498.65 | 2.74 | 2.74 |
| 494.66 | 3.64 | 3.64 |
| 492.64 | 3.42 | 3.42 |
| 623.80 | 3.90 | 3.90 |
| 404.53 | 1.73 | 1.73 |
| 552.70 | 3.05 | 3.05 |
| 551.73 | 4.25 | 4.25 |
| 616.78 | 4.14 | 4.14 |
| 553.75 | 4.04 | 4.04 |
| 556.73 | 3.45 | 3.45 |
| 463.60 | 1.57 | 1.57 |
| 538.71 | 3.26 | 3.26 |
| 418.56 | 2.07 | 2.07 |
| 574.75 | 4.31 | 4.31 |
| 536.69 | 3.47 | 3.47 |